1. Home
  2. FORM vs ARWR Comparison

FORM vs ARWR Comparison

Compare FORM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

SELL

Current Price

$81.75

Market Cap

6.4B

Sector

Technology

ML Signal

SELL

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$44.29

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
ARWR
Founded
1993
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.0B
IPO Year
2002
2009

Fundamental Metrics

Financial Performance
Metric
FORM
ARWR
Price
$81.75
$44.29
Analyst Decision
Buy
Strong Buy
Analyst Count
11
15
Target Price
★ $144.70
$106.07
AVG Volume (30 Days)
1.6M
★ 1.8M
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.89
N/A
Revenue
N/A
★ $16,142,321.00
Revenue This Year
$33.84
N/A
Revenue Next Year
$24.66
$109.46
P/E Ratio
$46.66
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$47.33
$37.06
52 Week High
$160.27
$95.49

Technical Indicators

Market Signals
Indicator
FORM
ARWR
Relative Strength Index (RSI) 39.97 19.23
Support Level $69.88 N/A
Resistance Level $105.71 $66.37
Average True Range (ATR) 6.85 2.87
MACD 0.39 -1.00
Stochastic Oscillator 28.01 1.25

Price Performance

Historical Comparison
FORM
ARWR

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: